Navigation Links
Solid in Biological Technology

METTLER TOLEDO Introduces an Affordable Reaction Block for Solid Phase Peptide Synthesis (SPPS)

METTLER TOLEDO offers an affordable reaction block for solid phase peptide synthesis and purification of peptide libraries: MiniBlock. For a limited time, you can register to win a MiniBlock® for Solid Phase Peptide Synthesis (SPPS). Columbia, MD (PRWEB) June 21, 2...

Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours

LAUSANNE, Switzerland and TAMPA, Florida, June 18 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Moffitt Cancer Center (Moffitt), a non-profit Fl...

Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors

- Results Presented at American Society of Clinical Oncology (ASCO) Meeting Show Fleximer(R) Conjugated Drug Is Well Tolerated with Favorable Pharmacokinetics and Prolonged Stable Disease in Refractory Tumors - CAMBRIDGE, Mass., June 1 /PRNewswire/ -- Mersana Therapeutics presented preliminar...

Quest PharmaTech Announces Results Showing its Photosensitizer, SL052, is an Effective Immuno-Stimulant when combined with Immunotherapy for the Removal of Solid Tumors

TSX Venture: QPT EDMONTON, March 4 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT), ("Quest" or the "Company") a pharmaceutical company developing and commercializing products for the treatment of cancer and dermatological conditions, today announced results from a study designed ...

Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer Schering Pharma AG

BETHESDA, Md., Jan. 12 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases today announced the signing of an option, collaboration and license agreement ...

Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research

Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science research and discovery solutions, today announced that its technology for next-generation genomic analysis, the SOLiD™ System, has been named the Life Science Innovation of the Yea...

Top Refractive Eye Surgeons Listed in Trusted LASIK Surgeons Directory Make Solid Showing at Annual Alcon Symposium

Doctors Stephen Brint, Daniel Durrie, Shachar Tauber, Stephen Slade, R. Wayne Bowman, William Whitson, James Salz, Ronald Krueger, Jason Stahl, Karl Stoneciper, Brock Magruder, and Richard Braunstein, attended the recent Alcon Symposium in Dallas, Texas, which featured the Allegretto Wave excimer...

Lilly Reports Solid Second-Quarter Results

Company reports double-digit sales and earnings growth INDIANAPOLIS, July 24 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) today announced financial results for the second quarter of 2008. Second-quarter results are presented on a reported basis. Reported results wer...

Fulcrum BioEnergy Announces Plans to Build One of the First Commercial-Scale Ethanol Plants Using Municipal Solid Waste as Feedstock

Plant to Provide an Attractive Domestic Alternative to High Priced Gasoline PLEASANTON, Calif., July 18 /PRNewswire/ -- Fulcrum BioEnergy, Inc., today announced that it is advancing next-generation ethanol production with its plans to build one of the first commercial-scale production facilities...

Renhuang Pharmaceuticals, Inc. Announces Solid Fourth Quarter and Fiscal Year 2007 Results

HARBIN, China, May 29 /Xinhua-PRNewswire-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or "the Company"), a leading pharmaceutical company in the People's Republic of China ("PRC"), today reported solid financial results for the fourth quarter and fiscal year end...

Chromatide and Novasep Have Extended Their Partnership to Develop Large Scale Solid Phase Peptide and Oligonucleotide Synthesis Technology.

POMPEY, France, May 16 /PRNewswire/ -- Chromatide and Novasep have extended their partnership to develop large scale solid phase peptide and oligonucleotide synthesis technology. The resulting systems and equipment will meet the growing needs of biotechnology and pharmaceutical industries for ...

China Medicine Announces Solid First Quarter 2008 Results

GUANGZHOU, China, May 12 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading distributor and developer of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines ("TCM"), nutritional and dietary-su...

Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference

HAYWARD, Calif., May 6 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN ) announced today that Jane Green, Kosan's Vice President, Corporate Communications, will present at the Leerink Swann Solid Tumors Roundtable Conference in New York at the Grand Hyatt Hotel on Frida...

Strong Double-Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol-Myers Squibb Company

- Reports Broad-Based Net Sales Growth of 20% from Continuing Operations Driven by Strong Performance of Pharmaceutical Business - Records Pre-Tax Earnings from Continuing Operations of $1.3 Billion Representing an Increase of 51% From First Quarter 2007 - Posts First Quarter ...

Lilly Reports Solid First-Quarter Results

Company delivers double-digit sales growth INDIANAPOLIS, April 21 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) today announced financial results for the first quarter of 2008. Financial results are presented on both a reported and a pro forma basis. Reported r...

Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook

Company Continues to Advance Product Pipeline with Increased Investment in Research & Development DEERFIELD, Ill., April 17 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: BAX ) today reported solid financial results for the first quarter of 2008, and raised ...

More solid than solid: A potential hydrogen-storage compound

One of the key engineering challenges to building a clean, efficient, hydrogen-powered car is how to design the fuel tank. Storing enough raw hydrogen for a reasonable driving range would require either impractically high pressures for gaseous hydrogen or extremely low temperatures for liquid hydr...

Masada Teams With Leading Waste Management Firm to Produce Ethanol From Municipal Solid Waste in the Dominican Republic

BIRMINGHAM, Ala., Dec. 12 /PRNewswire/ -- Masada Resource Group, LLC of Birmingham, Alabama, the world's leading municipal solid waste-to-ethanol technology firm, has teamed with RJ Zapata & Associates S.A., one of the largest privately owned groups of waste management companies in the Dominic...

Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction

- Automated Benchtop Workstation Aids Mass Spectrometer Analysis - HOPKINTON, Mass., Dec. 11 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP ) today announced the availability of the Zephyr SPE Workstation, a benchtop solution designed to automate Solid Phase Extraction...

SAFC Hitech(TM) Joins Aviza and ST Microelectronics for Solid State Technology ALD Webcast

ST. LOUIS, Oct. 30 /PRNewswire/ -- SAFC Hitech(TM), a focus area of SAFC(R) and part of the Sigma-Aldrich(TM) Corporation (Nasdaq: SIAL ), today announced that it will be participating in a webcast, along with representatives from Aviza Technology and ST Microelectronics, to discuss the subje...

Midwest Medium, Large-Cap Life Sciences Had Solid 2003

CHICAGO Last week, as part of our 2003 year-end biotech wrap up, I reviewed the performance of the Midwest biotech publicly traded companies. The region had an incredible year for this group. This week, lets a look at how the medium and large-cap Midwest life science companies fared in 2003. T...

Midwest large-cap life-science sector is solid in first quarter

Last week, we witnessed a biotech meltdown during the first quarter of 2005 amid poor overall stock market performance. This week, we will take a look at the larger cap life science companies. Note that these results dont include further bad news for the pharmaceutical sector. You may have not...

Bone Care marks solid quarter on Hectorol sales jump

Middleton, Wis. Bone Care International, Inc. , which makes the drug Hectorol, reported $2.5 million in profits on $22 million in sales for the quarter ended March 31. Hectorol is a Vitamin D-based drug used to lower abnormally high levels of parathyroid hormone in patients with chronic kidn...

To find solid security candidates, look beyond tech certificates

As more organizations see security and compliance as their top issues, they dont see where security really fits on the organization chart. There is a big secret that few executives know about in most organizations: Security is not a techie issue. It goes beyond knowing virus scans and firewalls. ...

Front-face detection for high-concentrate, opaque or solid sample

When working with highly-concentrated, opaque, or solid samples such as blood, paint, optical brighteners, living cells, polymer films, or phosphors, front-face fluorescence detection offers significant advantages for quantitative and qualitative fluorescence measurements. Highly concentrated a...

DOE awards $377 million in funding for 46 energy frontier research centers

...five years to simultaneously explore the light absorbing and emitting properties of hybrid inorganic-organic materials for solar energy conversion and solid state lighting. University of Texas, Austin (Austin, TX) $15 million for five years to pursue fundamental research on charge transfer processes t...

Growth spurts

... and at 300kV the electron beam has enough penetrating power to maintain high resolution, even when looking through a liquid confined between two thin solid windows," says NCEM director Dahmen. "Our resolution is significantly higher than any previous studies of this nature, which made it possible for us ...

Microfluidics International Corporation to Report Second Quarter 2009 Financial Results on August 11, 2009

...cs International Corporation applies its 20 years of high pressure processing experience to produce the most uniform and smallest liquid and suspended solid particles available, and has provided manufacturing systems for nanoparticle products for more than 15 years. The Company is a leader in advan...

ThermoGenesis Provides Update on Fiscal 2009 Results

...ngle said the following factors are expected to drive growth and contribute to improved financial performance for the Company in fiscal 2010: solid stem cell collection activity at our largest private cord blood banking customer, Cord Blood Registry ("CBR"). CBR expects these positive trends to c...

OncoGenex Reports Second Quarter 2009 Financial Results

...phase 2 clinical trials of OGX-011; - completion of its phase 1 clinical trial evaluating OGX-427 as a monotherapy in patients with solid tumors; - initiation of an investigator-sponsored phase 1 clinical trial evaluating OGX-427 treatment in patients with bladder cancer; and...

Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody

... potential of targeting cancer stem cells to treat solid tumors. OMP-21M18 is currently in Phase 1 clinica...an entirely new way of looking at the treatment of solid tumor cancers, recognizing that tumors are made up...a Phase 1 clinical trial in patients with advanced solid tumors. This trial will also assess pharmacokinet...

PDI Reports 2009 Second Quarter Financial Results

...al position and are optimistic that these efforts will pay off. Thus far in 2009, we have implemented a number of initiatives to advance PDI to a more solid competitive stance, including leveraging and expanding our core CSO capabilities, strategically adding to management, reducing expenses and taking app...

NxStage Reports Second Quarter 2009 Financial Results

...ith revenue of $31.6 million for the second quarter of 2008. The Company's second quarter performance was driven by systematic growth in Home, solid machine sales in Critical Care, and continued progress in In-Center, even within the current economic environment. Home revenue for the second quarte...

Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update

...ardiac safety study of picoplatin in patients with solid tumors. The study was designed in collaboration w...cardiograms. A total of 45 patients with advanced solid malignancies received 150 mg/meter squared of pico...latinum resistance associated with chemotherapy in solid tumors, and is being studied in multiple cancer in...

Micromet Closes $80.5 Million Public Offering of Common Stock

... clinical trial for the treatment of patients with solid tumors. MT110 binds to the epithelial cell adhesio...molecule, or EpCAM, which is overexpressed in many solid tumors. Micromet's human monoclonal antibody adeca...A BiTE antibody targeting CEA for the treatment of solid tumors is being developed in collaboration with Me...

VIASPACE Pursuing Renewable Energy Business in Asia

...s typically look for 20-year fuel supply agreements with extension options. Biomass power plants currently use agricultural waste and municipal solid waste for fuel. However, supplies of agricultural waste - including corn straw, wheat straw, rice straw and residuals from growing cotton - are season...

Biotech Hot in July Driven by Positive Drug Data and Acquisitions

...ot" in July driven by drug data, positive drug sales/earnings and partnering and M&A deals. As a result, the Burrill Biotech Select Index posted a solid monthly gain of 6.5 percent, mirroring the Dow and Nasdaq, which closed the month up 8.6 percent and 7.8 percent respectively marking their best perfo...

Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab

... clinical trial for the treatment of patients with solid tumors. MT110 binds to the epithelial cell adhesio...molecule, or EpCAM, which is overexpressed in many solid tumors. Micromet's human monoclonal antibody adeca...A BiTE antibody targeting CEA for the treatment of solid tumors is being developed in collaboration with Me...

Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City

... clinical studies in ovarian, breast and colorectal cancer. NKTR-105, PEGylated docetaxel, is currently in a Phase 1 study in patients with refractory solid tumors. Nektar technology is used in nine approved partnered products in the U.S. or Europe today, including UCB's Cimzia(R), Roche's PEGASYS(...

Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets

... clinical studies in ovarian, breast and colorectal cancer. NKTR-105, PEGylated docetaxel, is currently in a Phase 1 study in patients with refractory solid tumors. Nektar technology is used in nine approved partnered products in the U.S. or Europe today, including UCB's Cimzia(R), Roche's PEGASYS(R) fo...
Other Tags
(Date:4/15/2014)... The global experts who study the deadliest infectious diseases ... G. Ksiazek, professors at the University of Texas Medical ... annual International Symposium on Filoviruses. The filoviruses include Ebola ... 90 percent of people infected. The current outbreak of ... than 100 deaths so far. , "This award ...
(Date:4/15/2014)... nanoparticle form could help reduce side effects by targeting ... scientists have developed nanoparticles that deliver one or two ... design particles that can carry any more than that ... devised a new way to build such nanoparticles, making ... drugs. In a paper published in the Journal ...
(Date:4/15/2014)... of Adelaide research into parasites of cuttlefish, squid ... astonishing life cycles, and shown how they may ... Researcher Dr Sarah Catalano has described 10 new ... the kidneys of cephalopods (cuttlefish, squid and octopus). ... to be described from Australian waters. , ...
Breaking Biology News(10 mins):International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3Bizarre parasite may provide cuttlefish clues 2
(Date:4/14/2014)... dense, urban centers around the world, many people live ... tall buildings that block sunlight. And as the global ... together, the darkness will only spread. , To ... translucent panel that redirects sunlight onto narrow streets and ... over the edge at an angle, where it spreads ...
(Date:4/14/2014)... professor of chemical engineering at Virginia Tech , ... analyze living cells. The long-term goal is to gain ... In his lab , Lu and his students ... events inside cells. These devices promote high sensitivity and ... cells. , Based on their record of achievements, the ...
(Date:4/14/2014)... April 2014, Perth, Australia. Drug discovery company Proteomics ... development of a companion diagnostic (CDx) test with ... , The research team authenticated the panel of ... control samples. Seven biomarkers were validated at high ... , The mass spectrometry data was then cross-validated ...
(Date:4/14/2014)... for high-risk bladder cancer, chemotherapy before or after ... practice. The findings are published early online in ... American Cancer Society. , Clinical trials have shown ... bladder cancer who are given chemotherapy before surgery. ... surgery also improves survival. To investigate the use ...
(Date:4/11/2014)... control brain cell production could pave the way for ... Scientists have gained new understanding of the role played ... nerve and brain cells are formed a process ... healthy. Their findings could help explain what happens when ... fundamental characteristic of many diseases including cancer. , ...
Breaking Medicine News(10 mins):Health News:Let the sun shine in: Redirecting sunlight to urban alleyways 2Health News:Efficient analysis of small quantity of cells improves chances to understand disease 2
Other Contents